Nucala (mepolizumab) for the Treatment of Hypereosinophilic Syndrome (HES)

Mepolizumab is an IL-5-inhibiting humanised monoclonal antibody. Credit: GlaxoSmithKline.



  • Nucala (mepolizumab)
  • Nucala (mepolizumab)
  • Nucala (mepolizumab)